PMC:7717205 / 159-1815 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"16","span":{"begin":21,"end":68},"obj":"Species"},{"id":"17","span":{"begin":72,"end":89},"obj":"Species"},{"id":"18","span":{"begin":335,"end":343},"obj":"Species"},{"id":"19","span":{"begin":170,"end":179},"obj":"Disease"},{"id":"20","span":{"begin":262,"end":286},"obj":"Disease"},{"id":"21","span":{"begin":288,"end":296},"obj":"Disease"},{"id":"22","span":{"begin":349,"end":357},"obj":"Disease"},{"id":"23","span":{"begin":420,"end":441},"obj":"Disease"},{"id":"29","span":{"begin":587,"end":595},"obj":"Species"},{"id":"30","span":{"begin":681,"end":689},"obj":"Species"},{"id":"31","span":{"begin":700,"end":707},"obj":"Species"},{"id":"32","span":{"begin":622,"end":630},"obj":"Disease"},{"id":"33","span":{"begin":728,"end":749},"obj":"Disease"},{"id":"39","span":{"begin":833,"end":841},"obj":"Species"},{"id":"40","span":{"begin":915,"end":962},"obj":"Species"},{"id":"41","span":{"begin":1006,"end":1014},"obj":"Species"},{"id":"42","span":{"begin":1107,"end":1115},"obj":"Species"},{"id":"43","span":{"begin":871,"end":879},"obj":"Disease"},{"id":"50","span":{"begin":1246,"end":1254},"obj":"Species"},{"id":"51","span":{"begin":1409,"end":1417},"obj":"Species"},{"id":"52","span":{"begin":1508,"end":1516},"obj":"Species"},{"id":"53","span":{"begin":1260,"end":1268},"obj":"Disease"},{"id":"54","span":{"begin":1343,"end":1364},"obj":"Disease"},{"id":"55","span":{"begin":1522,"end":1543},"obj":"Disease"}],"attributes":[{"id":"A16","pred":"tao:has_database_id","subj":"16","obj":"Tax:2697049"},{"id":"A17","pred":"tao:has_database_id","subj":"17","obj":"Tax:2697049"},{"id":"A18","pred":"tao:has_database_id","subj":"18","obj":"Tax:9606"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D003643"},{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"MESH:C000657245"},{"id":"A21","pred":"tao:has_database_id","subj":"21","obj":"MESH:C000657245"},{"id":"A22","pred":"tao:has_database_id","subj":"22","obj":"MESH:C000657245"},{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"MESH:D010995"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"Tax:9606"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"Tax:9606"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"Tax:9606"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:C000657245"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"MESH:D010995"},{"id":"A39","pred":"tao:has_database_id","subj":"39","obj":"Tax:9606"},{"id":"A40","pred":"tao:has_database_id","subj":"40","obj":"Tax:2697049"},{"id":"A41","pred":"tao:has_database_id","subj":"41","obj":"Tax:9606"},{"id":"A42","pred":"tao:has_database_id","subj":"42","obj":"Tax:9606"},{"id":"A43","pred":"tao:has_database_id","subj":"43","obj":"MESH:C000657245"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Tax:9606"},{"id":"A51","pred":"tao:has_database_id","subj":"51","obj":"Tax:9606"},{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"Tax:9606"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"MESH:C000657245"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"MESH:D010995"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"MESH:D010995"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Abstract\n\nOBJECTIVES\nSevere acute respiratory syndrome coronavirus 2, a novel coronavirus, affects mainly the pulmonary parenchyma and produces significant morbidity and mortality. During the pandemic, several complications have been shown to be associated with coronavirus disease 2019 (COVID-19). Our goal was to present a series of patients with COVID-19 who underwent chest tube placements due to the development of pleural complications and to make suggestions for the insertion and follow-up management of the chest tube.\n\nMETHODS\nWe retrospectively collected and analysed data on patients with laboratory-confirmed COVID-19 in our hospital between 11 March and 15 May 2020. Patients from this patient group who developed pleural complications requiring chest tube insertion were included in the study.\n\nRESULTS\nA total of 542 patients who were suspected of having COVID-19 were hospitalized. The presence of severe acute respiratory syndrome coronavirus 2 was confirmed with laboratory tests in 342 patients between 11 March and 15 May 2020 in our centre. A chest tube was used in 13 (3.8%) of these patients. A high-efficiency particulate air filter mounted double-bottle technique was used to prevent viral transmission.\n\nCONCLUSIONS\nIn patients with COVID-19, the chest tube can be applied in cases with disease or treatment-related pleural complications. Our case series comprised a small group of patients, which is one of its limitations. Still, our main goal was to present our experience with patients with pleural complications and describe a new drainage technique to prevent viral transmission during chest tube application and follow-up."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T3","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"T4","span":{"begin":10,"end":20},"obj":"Sentence"},{"id":"T5","span":{"begin":21,"end":180},"obj":"Sentence"},{"id":"T6","span":{"begin":181,"end":298},"obj":"Sentence"},{"id":"T7","span":{"begin":299,"end":527},"obj":"Sentence"},{"id":"T8","span":{"begin":529,"end":536},"obj":"Sentence"},{"id":"T9","span":{"begin":537,"end":680},"obj":"Sentence"},{"id":"T10","span":{"begin":681,"end":808},"obj":"Sentence"},{"id":"T11","span":{"begin":810,"end":817},"obj":"Sentence"},{"id":"T12","span":{"begin":818,"end":898},"obj":"Sentence"},{"id":"T13","span":{"begin":899,"end":1062},"obj":"Sentence"},{"id":"T14","span":{"begin":1063,"end":1116},"obj":"Sentence"},{"id":"T15","span":{"begin":1117,"end":1229},"obj":"Sentence"},{"id":"T16","span":{"begin":1231,"end":1242},"obj":"Sentence"},{"id":"T17","span":{"begin":1243,"end":1365},"obj":"Sentence"},{"id":"T18","span":{"begin":1366,"end":1451},"obj":"Sentence"},{"id":"T19","span":{"begin":1452,"end":1656},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Abstract\n\nOBJECTIVES\nSevere acute respiratory syndrome coronavirus 2, a novel coronavirus, affects mainly the pulmonary parenchyma and produces significant morbidity and mortality. During the pandemic, several complications have been shown to be associated with coronavirus disease 2019 (COVID-19). Our goal was to present a series of patients with COVID-19 who underwent chest tube placements due to the development of pleural complications and to make suggestions for the insertion and follow-up management of the chest tube.\n\nMETHODS\nWe retrospectively collected and analysed data on patients with laboratory-confirmed COVID-19 in our hospital between 11 March and 15 May 2020. Patients from this patient group who developed pleural complications requiring chest tube insertion were included in the study.\n\nRESULTS\nA total of 542 patients who were suspected of having COVID-19 were hospitalized. The presence of severe acute respiratory syndrome coronavirus 2 was confirmed with laboratory tests in 342 patients between 11 March and 15 May 2020 in our centre. A chest tube was used in 13 (3.8%) of these patients. A high-efficiency particulate air filter mounted double-bottle technique was used to prevent viral transmission.\n\nCONCLUSIONS\nIn patients with COVID-19, the chest tube can be applied in cases with disease or treatment-related pleural complications. Our case series comprised a small group of patients, which is one of its limitations. Still, our main goal was to present our experience with patients with pleural complications and describe a new drainage technique to prevent viral transmission during chest tube application and follow-up."}